OBJECTIVE: Determine the incidence of refeeding syndrome, defined by the presence of hypophosphatemia in very-lowbirth-weight (VLBW) infants with intrauterine growth restriction (IUGR) compared with those without IUGR. STUDY DESIGN: In this retrospective cohort study, VLBW infants admitted over a 10-year period (271 IUGR and 1982 non-IUGR) were evaluated for specific electrolyte abnormalities in the first postnatal week. RESULT: IUGR infants were significantly more likely to have hypophosphatemia (41% vs 8.9%, relative risk (95% confidence interval: 7.25 (5.45, 9.65)) and severe hypophosphatemia (11.4% vs 1%, 12.06 (6.82, 21.33)) in the first postnatal week. The incidence of hypophosphatemia was significantly associated with the presence of maternal preeclampsia in all VLBW infants (odds ratio (OR): 2.58 (1.96, 3.40)) when controlling for birth weight and gestational age. CONCLUSION: Refeeding syndrome occurs in VLBW infants with IUGR and born to mothers with preeclampsia. Close monitoring of electrolytes, especially phosphorus, is warranted in this population.
INTRODUCTION
Intrauterine growth restriction (IUGR) or fetal growth restriction is defined as growth that deviates from the expected fetal growth pattern. It is related to significant physiologic impact on the growing fetus and is the second leading cause of perinatal morbidity and mortality. IUGR infants are at higher risk of neonatal complications and have been linked to increased risk of disease later in adulthood. 1 Placental insufficiency leads to a state of chronic malnourishment, which poses significant risk for the fetus.
Refeeding syndrome is a constellation of fluid and electrolyte dysregulation that occurs upon initiation of enteral or parenteral nutrition following a period of malnutrition or starvation. 2 In chronic malnutrition, glucose and glycogen stores are depleted, followed by an adaptation in metabolism where energy is then derived from lipolysis and ketone production. Following initiation of feeding, glucose metabolism results in increased phosphate usage for ATP production. This increased demand depletes serum stores of phosphorus and magnesium. 2 Hypophosphatemia is often accompanied by hypokalemia from intracellular shifts secondary to increased insulin, hyperglycemia secondary to excess glucose delivery in a system now adapted to fat metabolism, and significant vitamin deficiencies, thiamine in particular. 2 The physiologic disturbances, if untreated, can lead to life-threatening complications, including heart failure, arrhythmias, respiratory and neuromuscular compromise. 3, 4 This phenomenon has been extensively described in the anorexic, intensive care unit, and post-surgical adult and pediatric population but to date has not been reported in the neonatal population. 5, 6 In the neonatal population, IUGR secondary to placental insufficiency and altered oxygen delivery, results in a state of chronic, prolonged malnourishment that can be compared with that of the anorexic or critical surgical patient. It is hypothesized that IUGR neonates experience a similar 'refeeding' syndrome following the initiation of nutrition support after birth. The intent of this study was to evaluate the incidence of the characteristic electrolyte dyscrasias in IUGR vs non-IUGR very-low-birth-weight (VLBW) infants.
METHODS
We performed a retrospective cohort study based on the information extracted from a perinatal database containing 41000 data points and inpatient medical records. All VLBW patients (o1500 gm) admitted to the Neonatal Intensive Care Unit at the Medical University of South Carolina within the first 24 postnatal hours from 2001-2010 were included in the study. There were no additional exclusion criteria. The variables extracted included gestational age, birth weight, incidence of IUGR, small for gestational age (SGA) status, multiple gestation and days of mechanical ventilation. The occurrence of electrolyte abnormalities, including phosphorus, potassium, glucose and magnesium, occurring in first 7 postnatal days were collected on each patient. Incidence of maternal preeclampsia, maternal diabetes mellitus and neonatal complications, including bronchopulmonary dysplasia (BPD), late-onset sepsis, necrotizing enterocolitis, patent ductus arteriosus and grade 3/4 intraventricular hemorrhage, were also collected for comparison between groups and association with electrolyte dyscrasias. This study was approved by the institutional review board.
An infant was classified as IUGR based on the presence of obstetrical diagnosis at the time of delivery. SGA was defined as birth weight less than the 10th percentile on the Fenton growth curve. 7 The following cutoffs were used to define the collected electrolyte dyscrasiashypophosphatemia (phosphorus o4 mg dl À 1 ), severe hypophosphatemia (phosphorus o2.5 mg dl À 1 ), hypokalemia (potassium p3.0 mg dl À 1 ), hypomagnesemia (magnesium o1.5 mg dl À 1 ) and hyperglycemia (glucose4180 mg dl À 1 ). Over the 10-year period of the review, it was a standard practice for dextrose-containing intravenous fluids (2001) (2002) (2003) (2004) (2005) or dextrose-and protein-containing parenteral nutrition (2005) (2006) (2007) (2008) (2009) (2010) to be initiated immediately following the establishment of intravenous access. Throughout the study period, the standard practice included initiation of parenteral nutrition in all VLBW patients within the first 24--36 h of life. Standard concentrations of electrolytes, phosphorus (0.5-1 mM/ dl À 1 ), potassium (1.3-1.4 mEq dl À 1 ) and magnesium (0.3 mEq dl À 1 ) typically were added to parenteral nutrition by postnatal day 3. Enteral feeding practices, including timing of initiation and advancement of feeds, varied during the 10-year period. Standardized enteral feeding guidelines were developed, including trophic feeding schedule based on birth weight, initiation of enteral feeds within first 6 h of life and fortification of human milk at 100 ml kg À 1 per day, which occurs between postnatal day 7 and 12. Major changes in parenteral and enteral feeding practices were completed by 2006. Significant process changes in mechanical ventilation occurred over the 10-year study period. All major changes were completed in 2006, including a standardized ventilator management protocol, thus days of mechanical ventilation were evaluated for years 2007-2010.
Statistical analysis
This study was conducted to compare incidence of electrolyte dyscrasias between IUGR and non-IUGR VLBW infants. Statistical analysis was performed via w 2 test for non-continuous variables, Student's t-test for continuous variables and relative risk (RR). Ordinal values were compared by nonparametric Kruskal-Wallis test. Logistic regression was performed to evaluate clinical outcomes while controlling for certain clinical factors with resulting odds ratios (OR). A two-sided P-value of o0.05 was defined a priori as statistically significant.
RESULTS
A total of 2253 VLBW infants (271 IUGR and 1982 non-IUGR) were admitted to the Neonatal Intensive Care Unit within the first 24 postnatal hours during study period and were included in the analysis. Patient characteristics can be seen in Table 1 . The groups were significantly different for median gestational age, birth weight, sex, 5 min Apgar score and SGA status. Significantly more IUGR patients were born to mothers with preeclampsia as well. Overall morbidity and mortality in the first postnatal week did not differ between groups.
As shown in Table 2 , the incidence of hypophosphatemia and severe hypophosphatemia was significantly greater in the IUGR patients. The combination of hypophosphatemia and hypokalemia, as well as the combination of hypophosphatemia, hypokalemia and hyperglycemia were also significantly greater in the IUGR group. In addition, the diagnoses of hypomagnesemia alone and with other dyscrasias were significantly more likely in IUGR subjects.
Owing to the differences in mean birth gestational age and weight between the groups, logistic regression analysis was performed controlling for birth gestational age and weight. In these analyses, the associations between IUGR and hypophosphatemia, and IUGR and severe hypophosphatemia remained significant (OR: 6 As shown in Figure 1 , the prevalence of hypophosphatemia was higher in infants born to mothers with preeclampsia in both IUGR and non-IUGR infants. This difference was significant for the non-IUGR (17% vs 6.2%, RR: 3.26 (95% CI: 2.38, 4.47)) but not for the IUGR infants (46% vs 38%, RR: 1.39 (95% CI: 0.86, 2.27)). However, when controlling for birth weight and gestational age, a significant association was noted between IUGR infants with hypophosphatemia and the incidence of maternal preeclampsia (OR: 1.84; 95% CI: 1.19, 2.81; P ¼ 0.005). In addition, when controlling for birth weight and gestational age, all infants born to mothers with preeclampsia were significantly more likely to exhibit hypophosphatemia than those born to mothers without preeclampsia (OR: 2.58; 95% CI: 1.96, 3.40; Po0.0001). When controlling for birth weight, gestational age and IUGR status, there was no significant relationship between maternal diabetes mellitus and hypophosphatemia (OR: 1.34; 95% CI: 0.806, 2.23;
Owing to the significant changes in parenteral and enteral feeding methods that occurred over the 10-year period, the data were analyzed with a logistic regression model controlling for time period. Time period 2 (2006-2010) (1-7) ; Po0.0001, respectively). However, these differences did not remain significant when controlling for birth weight and gestational age. VLBW infants with hypophosphatemia were significantly more likely to require mechanical ventilation X3 days when compared with those without hypophosphatemia Refeeding syndrome in growth-restricted neonates JR Ross et al (Po0.0001) and these differences remained significant when controlling for gestational age and birth weight (OR: 1.76, 95% CI: 1.1, 2.70, P ¼ 0.0096).
DISCUSSION
In a cohort of 2253 VLBW infants, IUGR was associated with hypophosphatemia, hypokalemia, hyperglycemia and hypomagnesemia, which are laboratory markers of refeeding syndrome. These associations with IUGR status support the hypothesis of a refeeding syndrome in this population. Clinical manifestations of refeeding syndrome were originally described by Keys and Brozek in the 1940s during intentional experiments of the effects of starvation 8 and by Schnitker when malnourished prisoners of war died following reinitiation of regular nutrition. 9 Although clinically observed for years in the chronically malnourished patients, it was not officially reported and referenced as 'Refeeding Syndrome' until 1981. 10 The only additional study linking hypophosphatemia to growth restriction found that IUGR piglets fed high-protein formula had poor growth and hypotonia, with associated hypophosphatemia and hypokalemia. 11 This study is the first clinical evidence supporting the incidence of refeeding syndrome in the neonatal population and has important implications for the identification and management of those infants.
Phosphorus is essential for generation of ATP and its depletion has detrimental effects on cellular metabolism. Many studies have reported respiratory and neuromuscular failure as a result of hypophosphatemia secondary to refeeding syndrome. 4, 12, 13 A decrease in effective diaphragmatic contractility secondary to inadequate ATP is thought to be the primary mechanism for the observed respiratory failure.
14 In this study, although the incidence of hypophosphatemia was not associated with a significantly increased median ventilator days when controlling for gestational age and birth weight, it was associated with the requirement of mechanical ventilation for three or more days. The marker of 3 days was chosen based on our experience that most infants with uncomplicated respiratory distress syndrome require less than 24-48 h of mechanical ventilation post surfactant administration. Hypophosphatemia in refeeding syndrome typically becomes apparent around 3 days following refeeding 2, 15 and may contribute to at least short-term prolonged ventilation. As mechanical ventilation leads to volutrauma and barotrauma, thus increasing damage to the lungs; the length of mechanical ventilation days and the associated trauma and inflammation in these patients may lead to the increased incidence of BPD found in VLBW infants with hypophosphatemia. In addition, many maternal and neonatal factors have been linked to an increased incidence in BPD including maternal preeclampsia 16 and IUGR. [17] [18] [19] In this study, the relationship between BPD and hypophosphatemia remained when controlling for the presence of IUGR and maternal preeclampsia. No other studies have reported such a link between hypophosphatemia and BPD and additional study is needed to evaluate this relationship.
In addition to hypophosphatemia, IUGR infants were also at significantly increased risk of hypokalemia, hypomagnesemia and hypoglycemia. The full impact of these electrolyte disturbances were not completely evaluated in the scope of this study. Hypokalemia is known to cause decreased gut motility or ileus 20 and it could be hypothesized that the IUGR infants with refeeding syndrome have delayed achievement of full enteral feedings. Investigation into time to achieve full enteral nutrition and length of parenteral nutrition in this population is needed to further evaluate the clinical impact of refeeding syndrome. The finding of hypomagnesemia was surprising in this study and gives additional evidence to the constellation of findings associated with refeeding syndrome in this population. Standard therapy during labor with maternal preeclampsia is intravenous magnesium as seizure prophylaxis. Despite a high occurrence of preeclampsia in the IUGR population, the incidence of hypomagnesemia was significant. Maternal preeclampsia is identified as an independent risk factor for hypophosphatemia in this study. The increased risk of hypophosphatemia in non-IUGR infants, born to mothers with preeclampsia, raises concern that the risk refeeding syndrome is highest in infants subjected to states of malnutrition in utero even in the absence of growth restriction. Further evaluation of states of placental insufficiency and neonatal hypophosphatemia in the absence of overt growth restriction is warranted.
Refeeding syndrome and the associated electrolyte dyscrasias require the initiation of either enteral or parenteral nutrition. In this study, a significantly increased risk of hypophosphatemia and severe hypophosphatemia in IUGR patients was found in the 2006-2010 time period following many major changes in enteral and parenteral nutrition in this population. The combination of earlier parenteral nutrition with increased protein delivery, increased dextrose concentration due to earlier central line placement and early initiation of enteral nutrition without alteration in parenteral electrolyte management may contribute to the increased risk of electrolyte dyscrasias in this high-risk population.
Limitations of this study include the retrospective design. No standard protocol for monitoring of phosphorus existed during the study time. Thus, not all patients in the study had a phosphorus level measured in the first postnatal week of life. All patients were included in the data analysis and patients without phosphorus levels in the first postnatal week were analyzed as normal phosphorus. The study may also be limited by the definition of IUGR utilized to define cohort. The comparison based on obstetrical diagnosis of IUGR was chosen over SGA as a standard birth weight percentile measurement in order to better select those patients with pathologic growth restriction as opposed to constitutional small size. The IUGR condition is always pathologic and complicates as many as 7% of all pregnancies and up to 28% of pregnancies complicated by hypertension or preeclampsia. 21 It must be differentiated from SGA, which is defined as weight for gestation below a given threshold, commonly the 10th percentile, and is secondary to constitutional or physiological causes. 22 Thus, an infant may be IUGR without being SGA and an infant with SGA status may not be IUGR. Oxygen delivery is a primary determinant of fetal growth and thus IUGR is most commonly secondary to placental insufficiency. 23 Utilizing an obstetrical diagnosis of IUGR does have limitations as a lack of effective customized growth assessment has resulted in difficulty delineating between pathologic growth restriction and constitutional small growth, which is critical for risk assessment of the fetus. However, we feel as though this is an acceptable limitation in this study and best identifies the chronically malnourished population at risk for refeeding syndrome.
CONCLUSIONS
Hypophosphatemia poses significant risk to IUGR VLBW neonates. Its occurrence, in addition to associated hypokalemia, hypomagnesemia and hyperglycemia in IUGR VLBW infants is consistent with refeeding syndrome. Based on the results of this study, close monitoring of electrolytes, especially phosphorus, is warranted following initiation of parenteral or enteral nutrition in this patient population. Additional prospective studies evaluating trends in phosphorus levels over the first postnatal week of life in IUGR VLBW neonates are needed to better identify of those patients at highest risk for refeeding syndrome. Alterations in parenteral nutrition administration, including earlier administration of higher phosphorus and potassium, may decrease the incidence of electrolyte abnormalities and improve clinical outcomes, primarily the need for mechanical ventilation.
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